This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
The significant recent flooding across Queensland and New South Wales has impacted some vaccine deliveries. Practices are advised not to book appointments for patients until vaccine delivery has arrived.
General practices should be prepared to respond to flood or weather emergencies. In the past week alone, power outages occurred in the following CESPHN areas: Arncliffe, Bangor, Belfield, Campsie Caringbah, Centennial Park, Croydon Park, Engadine, Menai, Miranda, Paddington, Sutherland, Sylvania, Turrella, Wolli Creek, Woollahra, and Woronora. See Ausgrid website for power outage notifications and planned power outages.
General practices should work with their staff to make sure they are familiar with how to respond to an emergency. Review workforce to plan for staff being unable to attend work due to road closures. Remind staff about how to contact NSW State Emergency Services for help. General practice can replenish their stock of PPE via the CESPHN PPE request form if it is destroyed during a flooding event.
Please click here for further information on floods and vaccine storage distributed by CESPHN to general practices on 8 March 2022. Please click here for further information for pharmacies.
Japanese Encephalitis in NSW
On 7 March 2022, NSW Health confirmed two NSW residents with Japanese encephalitis virus (JEV) are currently being treated in hospital. NSW Heath are warning the public to be vigilant and safeguard themselves against mosquito bites. See Media release and Factsheet on Japanese encephalitis.
Flu vaccine update
ATAGI released advice including an update on the influenza vaccines and COVID-19 vaccines to support vaccination providers ahead of the 2022 influenza season. The influenza vaccines can now be co-administered (on the same day) with a COVID-19 vaccine.
Pre-allocation confirmation process for influenza vaccine opened on 7 Mar 2022. Providers must log in to NSW Vaccine Centre portal to approve their pre-allocated order. For more information see CESPHN Influenza website
Vaccine administration errors
New ATAGI guidelines provide advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended.
With several COVID-19 vaccines available to Australians, there is an increased risk of administration errors. Please ensure that the correct formulation or dosage size is used as recommended for the individual’s age and health status:
People aged 12 years and over should receive the Pfizer 12+ formulation (purple-cap).
Children aged 5 to 11 years should receive the Pfizer paediatric formulation (orange-cap). This is a smaller dose than the vaccine for people aged 12 years and over.
The only COVID-19 vaccine approved for children aged 5 years is the Pfizer paediatric formulation
There are currently no COVID-19 vaccines licensed for children aged 4 years and under.
The Moderna COVID-19 vaccine for children aged 6 to 11 years is half the dose used for the primary course for people 12 years and over but the same as the booster dose for adults. There is no paediatric-specific formulation for the Moderna vaccine.
Boosters are only authorised for people aged 16 years and over.
Should my child get a COVID-19 vaccine?
A new tool is now available to help parents make a decision about getting a COVID-19 vaccine for their children aged 5 to 15 years. Through five simple steps, the COVID-19 vaccine Decision aid for children (5 to 15 years) offers information to help parents and carers weigh up the risks and benefits of COVID-19 vaccination for their children.
Healthcare providers are encouraged to use this tool during consultations with patients to support discussions about COVID-19 vaccination in children. See also COVID-19 vaccine Decision aid (16+ years).
COVID-19 live stream update for GPs
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…